The Cs Mckee Lp holds 416,815 shares with $20.26M value, down from 430,485 last quarter. Abbott Labs now has $94.64B valuation. The stock traded within a range of $54.53 and $55.43. It has underperformed by 0.80% the S&P500.
Eqis Capital Management Inc increased Open Text Corp (OTEX) stake by 161.83% reported in 2017Q2 SEC filing. The hedge fund held 1.91M shares of the major pharmaceuticals company at the end of 2017Q2, valued at $92.89M, up from 203,735 at the end of the previous reported quarter. It closed at $23.07 lastly. Regulus Therapeutics Inc (NASDAQ:RGLS) has declined 73.20% since October 12, 2016 and is downtrending. It has underperformed by 0.80% the S&P500. At the moment, the average analyst rating for ABT is Moderate Buy. Therefore 50% are positive. Abbott Laboratories had 78 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has "Outperform" rating given on Friday, October 9 by RBC Capital Markets. The company has market cap of $39.07 million. The firm presently has a $61.00 target price on the healthcare product maker's stock. S&P Research maintained it with "Buy" rating and $34 target in Tuesday, October 20 report. The company was maintained on Saturday, August 29 by Deutsche Bank. TheStreet downgraded the shares of GE in report on Wednesday, August 26 to "Buy" rating. RBC Capital Markets has "Buy" rating and $5400 target. The stock has "Buy" rating by Cowen & Co on Monday, April 17. The firm has "Sell" rating by Citigroup given on Friday, April 8.
Investors sentiment decreased to 0.88 in Q2 2017. Its down 0.75, from 1.63 in 2017Q1. Ntv Asset Mngmt Lc owns 45,714 shares for 0.68% of their portfolio. Fifth Third Bancorp stated it has 1.1% in General Electric Company (NYSE:GE). McQueen Ball & Associates Inc. now owns 47,791 shares of the healthcare product maker's stock valued at $2,550,000 after acquiring an additional 1,311 shares during the period. Private Ocean Limited Liability reported 1,400 shares. Comerica Fincl Bank has invested 0.66% of its portfolio in General Electric Company (NYSE:GE). Citadel Advsr Limited Co reported 0% in Dynex Capital Inc (NYSE:DX). Following the completion of the transaction, the insider now directly owns 113,426 shares in the company, valued at $6,005,906.70. Bankshares invested in 0.83% or 156,493 shares. The New Jersey-based Mercer Cap Advisers has invested 0% in Diamond Offshore Drilling Inc (NYSE:DO). Canada Pension Plan Investment Board owns 1.34 million shares. They expect $0.50 EPS, up 56.25% or $0.18 from last year's $0.32 per share. DO's profit would be $32.05M giving it 15.84 P/E if the $0.23 EPS is correct. The healthcare product maker reported $0.62 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.60 by $0.02.
Since January 1, 0001, it had 0 insider purchases, and 1 sale for $101,964 activity. $54,660 worth of stock was bought by Gaffney Paul G on Monday, May 22. $2.81 million worth of stock was bought by IMMELT JEFFREY R on Monday, May 15. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.92% with $1.72 Billion sitting short, betting on future declines. It worsened, as 69 investors sold ABT shares while 545 reduced holdings. 102 funds opened positions while 441 raised stakes.
Among 24 analysts covering Abbott Laboratories (NYSE:ABT), 14 have Buy rating, 0 Sell and 10 Hold. 143.22 million shares or 1.03% less from 144.72 million shares in 2017Q1 were reported. Nebraska-based Farmers And Merchants has invested 0.48% in Abbott Laboratories (NYSE:ABT). The stock rose 0.60% or $0.2 reaching $33.65 per share. Gotham Asset Mgmt Lc holds 0.05% or 296,899 shares. Of Virginia Va accumulated 0.27% or 36,131 shares. It is 0.00% or $0 reaching $0.035 per share. Arizona State Retirement Sys invested 0.33% of its portfolio in Abbott Laboratories (NYSE:ABT). About 1.33 million shares traded. Papp L Roy And Assoc reported 0.1% of its portfolio in Abbott Laboratories (NYSE:ABT).
Abbott Laboratories (NYSE:ABT) last issued its quarterly earnings results on Thursday, July 20th. Gamco Investors Incorporated Et Al holds 67,633 shares or 0.02% of its portfolio. Barclays Capital upgraded Abbott Laboratories (NYSE:ABT) on Wednesday, October 7 to "Overweight" rating. During the same period previous year, the company earned $0.55 EPS. The analysts estimated EPS for the higher end at 0.75 and lower end at 0.71 while the year ago reported earnings per share was 0.7.
Since June 15, 2017, it had 0 buys, and 1 insider sale for $26,482 activity. Wells Fargo maintained Abbott Laboratories (NYSE:ABT) on Thursday, August 27 with "Buy" rating. Therefore 58% are positive.
A stock rating usually tells investors how well a stock's market value relates to what analysts think is a fair value for the stock, based on an independent evaluation of the company. Northland Capital downgraded Abbott Laboratories (NYSE:ABT) rating on Thursday, September 28. As per Thursday, July 30, the company rating was upgraded by RBC Capital Markets. The company was maintained on Friday, September 22 by Cowen & Co. The stock has "Outperform" rating by RBC Capital Markets on Friday, October 9. The firm has "Buy" rating given on Monday, August 10 by Maxim Group. The firm has "Neutral" rating given on Wednesday, September 21 by Goldman Sachs. As per Monday, January 30, the company rating was maintained by Wedbush.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.